z-logo
open-access-imgOpen Access
CD155 and CD112 as possible therapeutic targets of FLT3 inhibitors for acute myeloid leukemia
Author(s) -
Yuta Kaito,
Mitsuhito Hirano,
Muneyoshi Futami,
Masanori Nojima,
Hideto Tamura,
Arinobu Tojo,
Yoichi Imai
Publication year - 2021
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2021.13169
Subject(s) - tigit , cytotoxicity , cancer research , biology , myeloid leukemia , natural killer cell , immune system , t cell , immunology , in vitro , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom